Abstract
Keratinocyte stem cells (KSCs) can be cultured in vitro and are thus attractive in epidermal sheet gene therapies for genodermatoses. However, the growth and expansion in in vitro culture of primary keratinocytes (including KSCs) can be inefficient as KSCs isolated from skin biopsies and dissociated from their surrounding cells and extracellular matrix undergo apoptotic cell death, known as anoikis. This affects the survival and stemness of KSCs, hindering clinical applications. Rho-associated kinase inhibitor (ROCKi) has been widely used to overcome this obstacle, but the risk of changing the characteristics of stem cells remains.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callSimilar Papers
More From: Journal of Investigative Dermatology
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
